Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1
<p>Abstract</p> <p>We describe a novel strategy in which two inhibitors of HIV viral entry were incorporated into a single molecule. This bifunctional fusion inhibitor consists of an antibody blocking the binding of HIV to its co-receptor CCR5, and a covalently linked peptide which...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-05-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/5/1/56 |
id |
doaj-2f40e1c837204ad49811da95d8786d5a |
---|---|
record_format |
Article |
spelling |
doaj-2f40e1c837204ad49811da95d8786d5a2020-11-25T01:10:53ZengBMCVirology Journal1743-422X2008-05-01515610.1186/1743-422X-5-56Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1Cammack NickFischer StephanZhang JunRao EileenJi ChanghuaJekle AndreasKopetzki ErhardSankuratri SuryaHeilek Gabrielle<p>Abstract</p> <p>We describe a novel strategy in which two inhibitors of HIV viral entry were incorporated into a single molecule. This bifunctional fusion inhibitor consists of an antibody blocking the binding of HIV to its co-receptor CCR5, and a covalently linked peptide which blocks envelope mediated virus-cell fusion. This novel bifunctional molecule is highly active on CCR5- and X4-tropic viruses in a single cycle assay and a reporter cell line with IC<sub>50 </sub>values of 0.03–0.05 nM. We demonstrated that both inhibitors contribute to the antiviral activity. In the natural host peripheral blood mononuclear cells (PBMC) the inhibition of CXCR4-tropic viruses is dependant on the co-expression of CCR5 and CXCR4 receptors. This bifunctional inhibitor may offer potential for improved pharmacokinetic parameters for a fusion inhibitor in humans and the combination of two active antiviral agents in one molecule may provide better durability in controlling the emergence of resistant viruses.</p> http://www.virologyj.com/content/5/1/56 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cammack Nick Fischer Stephan Zhang Jun Rao Eileen Ji Changhua Jekle Andreas Kopetzki Erhard Sankuratri Surya Heilek Gabrielle |
spellingShingle |
Cammack Nick Fischer Stephan Zhang Jun Rao Eileen Ji Changhua Jekle Andreas Kopetzki Erhard Sankuratri Surya Heilek Gabrielle Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1 Virology Journal |
author_facet |
Cammack Nick Fischer Stephan Zhang Jun Rao Eileen Ji Changhua Jekle Andreas Kopetzki Erhard Sankuratri Surya Heilek Gabrielle |
author_sort |
Cammack Nick |
title |
Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1 |
title_short |
Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1 |
title_full |
Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1 |
title_fullStr |
Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1 |
title_full_unstemmed |
Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1 |
title_sort |
closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of hiv-1 |
publisher |
BMC |
series |
Virology Journal |
issn |
1743-422X |
publishDate |
2008-05-01 |
description |
<p>Abstract</p> <p>We describe a novel strategy in which two inhibitors of HIV viral entry were incorporated into a single molecule. This bifunctional fusion inhibitor consists of an antibody blocking the binding of HIV to its co-receptor CCR5, and a covalently linked peptide which blocks envelope mediated virus-cell fusion. This novel bifunctional molecule is highly active on CCR5- and X4-tropic viruses in a single cycle assay and a reporter cell line with IC<sub>50 </sub>values of 0.03–0.05 nM. We demonstrated that both inhibitors contribute to the antiviral activity. In the natural host peripheral blood mononuclear cells (PBMC) the inhibition of CXCR4-tropic viruses is dependant on the co-expression of CCR5 and CXCR4 receptors. This bifunctional inhibitor may offer potential for improved pharmacokinetic parameters for a fusion inhibitor in humans and the combination of two active antiviral agents in one molecule may provide better durability in controlling the emergence of resistant viruses.</p> |
url |
http://www.virologyj.com/content/5/1/56 |
work_keys_str_mv |
AT cammacknick closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT fischerstephan closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT zhangjun closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT raoeileen closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT jichanghua closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT jekleandreas closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT kopetzkierhard closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT sankuratrisurya closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 AT heilekgabrielle closingtwodoorsofviralentryintramolecularcombinationofacoreceptorandfusioninhibitorofhiv1 |
_version_ |
1725173639604600832 |